Glycerol fatty acid esters (GFAEs) are recognized for their potential to improve lipid metabolism, energy utilization, and gut health due to their excellent emulsifying and antimicrobial properties. The objective of this research was to investigate the effects of dietary GFAE supplementation on production performance, serum biochemical profiles, and rumen fermentation in beef cattle. Thirty crossbred Simmental bulls, averaging 507.42 ± 9.59 kg in body weight, were assigned to three distinct cohorts, with 10 animals in each cohort. The CON cohort was fed a basal diet devoid of GFAE, whereas the treatment cohorts (GFAE1 and GFAE2) received GFAE supplements at concentrations of 0.1% and 0.2% of the dietary dry matter, respectively. Compared with the control group, supplementation with 0.1% GFAE significantly increased the ADG of beef cattle by 12.14% (p < 0.05); compared with the GFAE2 group, ADG was 7.86% higher (p > 0.05). The digestibility of NDF and ADF was significantly enhanced in the GFAE1 group relative to the control group (p < 0.05). Dietary GFAE supplementation significantly elevated rumen acetate, propionate, and total volatile fatty acid concentrations in both the GFAE1 and GFAE2 groups compared to the control group (p < 0.05). In contrast to the control group, there was a notable rise in serum levels of T-AOC, UREA, and TG in both GFAE1 and GFAE2 groups (p < 0.05). Conversely, the concentration of HDL-C was significantly decreased in the GFAE2 group. Additionally, at the phylum level, the abundance of Fibrobacterota was significantly higher in the GFAE1 group than in the control group (p < 0.01). At the genus level, the proportions of Bacteroides and Fibrobacter were significantly higher in the GFAE1 group compared to the control group (p < 0.05). In conclusion, this study demonstrates that the addition of 0.1% GFAE to beef cattle diets significantly enhances the digestibility of ADF and NDF nutrients, increases serum total antioxidant capacity, urea, and triglycerides, optimizes rumen fermentation parameters and microbial community structure, and ultimately improves production performance. As a result of the findings from this research, it is suggested that 0.1% GFAE be incorporated into the diet for beef cattle.

Lumpy skin disease (LSD) is a contagious animal disease caused by the lumpy skin disease virus (LSDV). LSD can be transmitted through direct, indirect and insect vectors, severely impacting global cattle production. To evaluate difference in immune response and gut microbiota of 30 healthy 16–18 months old Angus cattle, treated with live attenuated or inactivated goatpox vaccine virus strains. The cattle were randomly divided into three groups (10 animals per group): Group A—goatpox live attenuated vaccine; Group B—goatpox inactivated vaccine; Group C—control (saline). Blood samples were collected on days 14, 28, 42, and 56 post-vaccination to assess hematological parameters, serum biochemical indices, and antibody levels; rectal feces were collected on day 28 for 16S rRNA analysis of gut microbiota. Results showed that, on day 28, both Group A and Group B reached their peak antibody levels (the log₁₀ value of Group A was 2.6, and that of Group B was 2.7), with about 90% of the cattle in each vaccinated group testing antibody-positive. On day 42, Group B retained 90% seropositivity, whereas Group A declined to 80%. Significantly altered in vaccinated Groups (A and B) compared to controls on days 14 and 28 (p < 0.05). Hematological parameters (PLT, NEUT, and LYM) and serum biochemical indices (AST, TP, and GGT) were elevated early after vaccination but returned to baseline by days 42 and 56.Which returned to control levels by days 42 and 56. On day 28 post-vaccination, Vaccinated cattle showed significantly higher gut microbiome richness and diversity than unvaccinated controls (p < 0.05). At the phylum level, the dominance was observed in Firmicutes and Bacteroidetes: the relative abundances were 62.90% and 29.65% in Group A, 60.84% and 30.13% in Group B, and 49.99% and 39.73% in Group C, respectively. These findings indicate that the inactivated goatpox vaccine elicits a more durable and stable antibody response, maintaining higher specific antibody titers, and induces more pronounced shifts in the gut microbiota community structure at the phylum level compared with the live attenuated vaccine.